Department publishes revised agenda for the September 2023 PBAC meeting

31 August 2023 - The agenda for this month's intracycle meeting has been updated. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 September 2023

1 September 2023 - The September 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Australia knocks back application for diabetes drug that could overshadow Ozempic

29 August 2023 - Australia has knocked back an application to subsidise the diabetes drug Mounjaro but the manufacturer still wants ...

Read more →

Efficient Funding of Chemotherapy Review – final report

28 August 2023 - The final report of the Efficient Funding of Chemotherapy Review is now available. ...

Read more →

Agenda for the September 2023 PBAC intracycle meeting

25 August 2023 - The agenda for the September 2023 PBAC intracycle meeting is now available. ...

Read more →

Public Summary Documents – May 2023 PBAC meeting

25 August 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2023 PBAC ...

Read more →

Estimating overall survival in people receiving PBS listed cancer medicines in Australian clinical practice

18 August 2023 - In September 2021, the Department of Health and Aged Care contracted the Medicines Intelligence Centre for ...

Read more →

New treatments for people with chronic migraine and soft tissue sarcoma added to the PBS

14 August 2023 - From August 2023, Australians with chronic migraine and soft tissue sarcoma will have access to new ...

Read more →

Medicine costs to halve after Labor wins 60 day dispensing vote

10 August 2023 - More than six million Australians will have the cost of their medi­cines halved within weeks as ...

Read more →

Senate showdown on 60 day dispensing

9 August 2023 - Health Minister Mark Butler has accused the Coalition and Pharmacy Guild of Australia of wanting to ...

Read more →

Global sarcoma therapy now listed on Pharmaceutical Benefits Scheme

31 July 2023 - Yondelis (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 August 2023

1 August 2023 - The August 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

International harmonisation of ingredient names - changes to the PBS Schedule effective 1 August 2023

PBAC - The PBS Schedule has been updated in the 1 August 2023 Schedule to show sole ingredient names for ...

Read more →

DoH publishes agenda for November 2023 PBAC meeting

26 July 2023 - The agenda for the November 2023 PBAC meeting is now available. ...

Read more →

DUSC utilisation analysis public release documents (February 2023)

20 July 2023 - The utilisation analysis public release documents from the February 2023 DUSC meeting are now available. ...

Read more →